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Abstract
Background: MicroRNAs are small non-coding RNAs that post-transcriptionally regulate gene
expression and their expression is frequently altered in human diseases, including cancer. To
correlate clinically relevant parameters with microRNA expression, total RNA is frequently
prepared from samples that were archived for various time periods in frozen tissue banks but,
unfortunately, RNA integrity is not always preserved in these frozen tissues. Here, we investigate
whether experimentally induced RNA degradation affects microRNA expression profiles.
Results: Tissue samples were maintained on ice for defined time periods prior to total RNA
extraction, which resulted in different degrees of RNA degradation. MicroRNA expression was
then analyzed by microarray analysis (miCHIP) or microRNA-specific real-time quantitative PCR
(miQPCR). Our results demonstrate that the loss of RNA integrity leads to in unpredictability of
microRNA expression profiles for both, array-based and miQPCR assays.
Conclusion: MicroRNA expression cannot be reliably profiled in degraded total RNA. For the
profiling of microRNAs we recommend use of RNA samples with a RNA integrity number equal
to or above seven.
Background
MicroRNAs (miRNAs) are evolutionary conserved, small,
non-coding RNAs that post-transcriptionally control the
expression of protein coding genes [1,2] in diverse cellular
processes such as differentiation [3,4], proliferation [5]
and apoptosis [6]. Differential miRNA expression has
been detected in human malignancies [7-10] and thus,
specific changes in miRNA expression may provide valua-
ble diagnostic and prognostic information [11,12]. The
ability to reliably quantify miRNA expression in archived
tissue collections would simplify retrospective studies by
allowing correlations between a given disease state with a
specific miRNA signature. Large numbers of clinical sam-
ples are preserved either in liquid nitrogen (preserving
nucleic acid and proteins) or as Formalin-Fixed Paraffin-
Embedded blocks (FFPE, preserving tissue morphology).
For these samples, the clinical history and the clinical out-
come (e.g. baseline parameters, response to treatment,
and recurrence of the disease or survival rate) are fre-
quently known. Unfortunately, RNA integrity is not
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always preserved in these archived tissues, with studies
indicating that RNA extracted from FFPE blocks is partic-
ularly highly degraded [13]. However, the miRNA profiles
obtained from FFPE extracted and snap-frozen extracted
total RNA are comparable [14-16], suggesting that miR-
NAs may escape the chemical degradation induced by for-
malin fixation.
To our knowledge, RNA integrity and its effect on miRNA
detection has not been studied in snap-frozen specimens.
We therefore addressed the question to what extent total
RNA degradation affects miRNA profiles. Our data show
that total RNA degradation in defrosted tissues signifi-
cantly affects miRNA integrity. The lower the quality of
total RNA, the higher the proportion of miRNAs that
show aberrant signal intensities in microarray and qPCR
based approaches. Importantly, we could not identify any
systematic effect on the degradation of specific miRNAs
that would allow for appropriate correction. Based on
these findings, we concluded that reliable miRNA expres-
sion profiles using microarrays and qPCR are only
achieved if total RNA with RNA Integrity Number (RIN)
equal to or above seven is used.
Results
RNA degradation in archived snap-frozen tissues
RNA can be readily damaged by heat, UV, acid or base cat-
alyzed hydrolysis and by enzymatic degradation. How-
ever, individually these approaches do not replicate the
diverse insults that occur during the extraction of total
RNA from frozen tissues. To mimic total RNA degradation
in snap-frozen livers and duodenums from mice, tissues
were stored in a -80°C freezer and then transferred to dry
ice. Each frozen tissue was sliced into five identical pieces
which then were transferred into eppendorf tubes. At time
point zero (T0), all samples were placed on ice and total
RNA was extracted immediately from (T0) and at later
time points [30 min (T30), 60 min (T60), 120 min (T120)
and 240 min (T240)]. RNA integrities were assessed using
the Agilent Bioanalyzer 2100 which calculates RIN values
of assayed RNAs (Figure 1). The RIN is the computational
output of an algorithm which ranks several parameters
obtained from the electropherograms, assigning a numer-
ical value to RNA integrity [17,18]. We found that at T0,
the RNA integrity for both tissues was above 7, indicating
good quality total RNA. However, 30 min on ice was suf-
ficient to reduce RNA integrity, indicated by the decrease
in RINs (Figure 1A, liver; 1B, duodenum). These findings
indicate that RNA degradation can take place in defrosted
tissue at low temperature (i.e. on ice).
RNA degradation in freshly harvested tissues
For comparison, we assessed the extent to which RNA
integrity is preserved in freshly harvested tissues when tis-
sue processing is delayed. Liver and duodenum samples
were collected from mice and either processed immedi-
ately or maintained on ice, as described above. Bioana-
lyzer electropherograms of the liver samples did not
indicate any significant total RNA degradation even when
samples remained on ice for up to 4 hrs (Figure 1C). By
contrast, duodenal samples (which are rich in RNases) do
show high susceptibility to degradation similar to the
snap-frozen defrosted material (Figure 1D). These find-
ings suggest that tissues such as duodenum or pancreas
should either be processed immediately or snap-frozen
and processed individually.
miRNAs are degraded in low integrity total RNA
A commonly held belief is that small RNAs, including
miRNAs, are only marginally affected by degradation,
compared to larger mRNAs. To evaluate if miRNA integ-
rity is affected by total RNA degradation, we analyzed
miR-122 expression in previously frozen hepatic samples
(Figure 2) by northern blotting. Northern blotting offers
both quantitative and qualitative information about indi-
vidual miRNAs [19]. Visual inspection of the bands and
phosphoimager quantitation of the signals clearly show a
decrease in miR-122 intensity in those RNA samples with
lower RIN values. By design, all analyzed RNAs were pre-
pared from the same liver and in consequence differences
in miR-122 signals are attributable to RNA degradation.
Total RNA samples with the lowest RIN values exhibit the
lowest miR-122 signals. For example, following 120 min
incubation on ice, total RNA prepared from liver shows a
RIN value of 2.8 and has 2.6-fold less miR-122 signal
compared to T0 control. Based on this result, we predict
that miRNAs are indeed susceptible to degradation and
that miRNAs within degraded samples are affected by the
degradation process.
miRNA expression profiling of degraded RNAs
The introduction of microarray technology has allowed
the analysis of the complete transcriptome of a given cell-
type or tissue in a single experiment. We have recently
established a novel microarray platform (miCHIP) that
accurately and sensitively monitors the genome-wide
expression of known mature miRNAs and that discrimi-
nates between closely related miRNA family members
[20,21]. To assess to which extent total RNA degradation
affects miRNA expression profiles, we hybridized total
RNAs extracted from liver and duodenum to the miCHIP
microarray. Hierarchical clustering (HCL), by Pearson
correlation, was used to cluster samples based on their
miRNA expression profiles (Figure 3). These analyses
show that even samples with the most degraded RNAs still
preserve a tissue-specific miRNA signature. Based solely
upon miCHIP array data analysis with HCL, we can con-
clude that RNA degradation does not significantly com-
promise miRNA tissue-specific signatures.
HCL is a robust, global, analytical technique that clusters
expression profiles but does not reflect changes in expres-BMC Biotechnology 2009, 9:102 http://www.biomedcentral.com/1472-6750/9/102
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sion of individual miRNAs. To evaluate changes in expres-
sion of individual miRNAs we organized the data into
scatter plot matrices (Figure 4). A scatter plot matrix
presents multiple variables by pair-wise evaluation. Com-
parison of samples with high versus low RINs (e.g. liver T0
RIN, 7.2 vs T120 RIN, 2.8; Figure 4A) shows that samples
with degraded total RNA increase the proportion of miR-
NAs classified as significantly regulated. This is also true
when comparing degraded samples with similarly low
RINs (i.e. duodenum T120 RIN, 2.7 vs T240 RIN, 2.5; Fig-
ure 4B) which generate a significant number of falsely
positive regulated miRNAs. For comparison we have
hybridized to miCHIP RNAs extracted from freshly har-
vested livers and duodenums (Figure 5). Our data show
that miRNAs extracted from freshly harvested liver is less
degraded, as evident from the matrix plot analyses (Figure
5A). Consistent with high level of RNases present in duo-
denum, miRNAs from freshly harvested duodenum are
extensively degraded (Figure 5B). Based on these data, we
conclude that samples with low RIN values (less than 7)
do not merit analysis on miRNA arrays.
Degradation of total RNA randomly affects miRNAs
Next, we assessed if total RNA degradation systematically
affects miRNA profiles and if so, to devise methods to cor-
rect for systematic errors. For this purpose we filtered scat-
ter plot matrices (see Figure 4) and selected those capture
probes which show regulation by at least two fold in any
of the scatter plots (for the complete list of probes see
Additional file 1 - Table S1). To identify whether any cap-
ture probe was systematically affected by the degradation,
we calculated the overlap between the probe lists (Figure
6). Our analysis shows that, within each tissue (i.e. liver
and duodenum) we could not identify over-represented
capture probes, indicating that under our experimental
Assessment of total RNA degradation Figure 1
Assessment of total RNA degradation. Electropherograms from high quality total RNA present three distinct peaks (28S, 
18 S and 5S). The presences of multiple peaks or smears indicate RNA degradation. Electropherograms of total RNA extracted 
from snap-frozen liver (A) or duodenal (B) samples or from total RNA extracted from fresh liver(C) or fresh duodenum (D) 
immediately (T0) or after incubation in ice for 30 min (T30), 60 min (T60), 120 min (T120) and 240 min (T240). Total RNA 
extracted from snap-frozen tissues and fresh duodenum is affected by degradation as early as 30 min on ice. RNA extracted 
from fresh livers is only slightly affected by degradation even after 4 hours in ice. (M, Marker; 1, T0; 2, T30; 3, T60; 4, T120 and 
5, T240).BMC Biotechnology 2009, 9:102 http://www.biomedcentral.com/1472-6750/9/102
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conditions miRNA degradation occur randomly and
therefore cannot be systematically corrected.
miRNA analysis by qPCR
We next tested whether degradation of total RNA also
affects expression profiles of miRNAs by using miRNA
specific qPCR. For this purpose, we synthesized cDNA
from hepatic total RNA (T0, T30, T60, T120 and T240)
and analyzed it by the miQPCR method (manuscript in
preparation). The abundance of seven liver-expressed
miRNAs (Let-7b, Let-7c, Let-7d, miR-122, miR-16, miR-
192 and miR-194) and of RNU6 was analyzed by using
SYBR Green and the crossing threshold value (Ct [22])
determined for each condition (Figure 7). These analyses
indicate that despite the fact that miRNAs have short
amplicons the relative amount that we can detect by
miQPCR is compromised by RNA degradation. Different
miRNAs are compromised to different extents within the
same RNA sample, again indicating that degradation is
random and cannot be corrected by post-analytical
processing.
Discussion
Correlation of miRNA expression patterns with clinically
relevant information is greatly facilitated by the retrospec-
tive analysis of samples archived in tissue banks. Unfortu-
nately, the quality of samples stored in tissue banks is
variable due to heterogeneity in pre-analytical preparation
of clinical specimens. Collectively, these variables will
impact the reliability of the results of the analysis. While
total RNA extracted from FFPE blocks is severely degraded,
several studies suggest that the miRNA profiles are not sig-
nificantly compromised despite total RNA degradation
arisen from formalin fixation [14-16]. These reports
strengthen the commonly held misconception that the
short size of mature miRNAs allows them to escape degra-
dation.
To date no systematic studies have been performed to
investigate the relationship between total RNA degrada-
tion and miRNA profiles determined from snap-frozen
tissue collections. To investigate this question, we com-
pared miRNA expression profiles generated through
delaying the extraction of RNA from liver and duodenum,
to generate different RNA integrities as defined by RIN val-
ues. Northern blot analysis shows that the amount of
miR-122 decreases in those samples with lower RIN val-
ues (Figure 2). In addition, we observe that signal intensi-
ties determined by miCHIP microarray are significantly
affected when total RNA degradation is observed (Figure
4, 5, 6 and 7). Correlation of the RIN numbers (Figure 1)
with the number of "degradation-regulated" capture
probes (See Additional file 1 - Table S1) show that miR-
NAs in the duodenal tissue are affected more severely by
degradation compared to miRNAs in the liver.
Previous studies indicate that low RNA integrity still per-
mits the use of short amplicons to reliably monitor mRNA
expression by qPCR [23]. By contrast, our data clearly
demonstrate that this does not apply to miRNA expres-
sion profiling by qPCR. We show that extracted RNA sam-
ples that are highly degraded, as characterized by low
RINs, containing between two to eight fold less miRNA
than compared to the control (T0) RNA (Figure 7).
Collectively, our findings demonstrate that total RNA deg-
radation affects miRNAs as detected by northern blot
analysis, array-based miRNA profiling and by miRNA-spe-
cific qPCR. Inclusion of samples with degraded total RNA
in miRNA expression profiling experiments reduces the
analytical power of the analysis through increasing the
variation within the experiment, rendering it more diffi-
cult to detect biologically significant miRNA signatures
reliably.
Analysis of miRNA degradation by Northern blot analysis Figure 2
Analysis of miRNA degradation by Northern blot 
analysis. To evaluate how degradation of total RNA affects 
miRNA integrity the liver specific miR-122 was selected. The 
top panel shows ethidium bromide stained 5S RNA as a load-
ing control. In the bottom panel background-corrected signal 
intensities of the northern blot are calculated by ImageJ. The 
signal corresponding to the miRNA with the highest signal 
intensity (T0) was set to 100%, and signals for the other sam-
ples were calculated as a percentage of it. The position of the 
mature miR-122 is indicated (middle panel).BMC Biotechnology 2009, 9:102 http://www.biomedcentral.com/1472-6750/9/102
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Conclusion
We conclude that there is no suitable methodology for the
reliable and reproducible analysis of miRNA expression of
poor quality RNA samples. In order that miRNA expres-
sion profiles reflect true biological differences and not var-
iation imposed by RNA integrity, we propose that only
total RNA with integrity equal to, or higher than RIN
seven should be included for miRNA expression analysis.
Methods
Study design and RNA preparation
Snap-frozen livers and duodenum collected from female
mice of Bl6/57 genetic background were stored in the -
80°C for more than 12 months. In order to obtain RNA of
different quality frozen tissues were cut in five fragments
of similar size, placed into individual eppendorf tubes
and stored in dry ice. At time point zero (T0) samples were
miCHIP analysis of miRNA expression Figure 3
miCHIP analysis of miRNA expression. Hierarchical clustering was used to assess which samples cluster together based 
on their miRNA expression profiles. The data show that even severely degraded total RNA samples are defined by tissue-spe-
cific miRNA signatures. The key color bar shows miRNA expression levels (dark red indicates high signal intensities, while dark 
blue indicates no detectable signal).
Scatter plot matrices, snap-frozen tissues Figure 4
Scatter plot matrices, snap-frozen tissues. Matrix plots indicating miRNA expression in snap-frozen samples. Compari-
son of samples with high versus low RINs for both liver (A) and duodenum (B) show that severe total RNA degradation 
increases the proportion of miRNAs classified as significantly regulated.BMC Biotechnology 2009, 9:102 http://www.biomedcentral.com/1472-6750/9/102
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moved into ice and at different time points 1 ml of Trizol
(Invitrogen) was added to the sample. Tissues were imme-
diately disrupted by using mechanical shearing (Tissue-
lyzer, Qiagen). Total RNA containing small RNA was
extracted from the homogenate as previously described
[20,21]. RNA concentration and RNA quality were
assessed by NanoDrop ND100 (NanoDrop Technologies)
and Agilent 2100 Bioanalyzer (Agilent Technologies). For
comparison, we harvested livers and duodenums from
Bl6/57 female mice. Freshly collected tissues were trans-
ferred in ice and processed as described above.
Northern blotting
Northern blot analysis was performed as described [21],
10 μg of total RNA were loaded onto denaturing Poly Acr-
ylamide Gel Electrophoresis (PAGE) and run alongside an
appropriate DNA marker. Following electrophoresis, RNA
was transferred to nylon membrane using semidry trans-
fer (Semiphor; Pharmacia Biotech). Membranes were
then hybridized overnight at 50°C in Phosphate hybridi-
zation buffer, together with LNA oligonucleotides (miR-
CURY LNA Array detection probes; Exiqon) that were
previously labeled with P32 by using PNK (Poly Nucle-
otide Kinase, NEB). Signal intensities were recorded by
using phosphoimager (Toshiba) and normalized by using
non-saturated images of ethidium bromide stained gel
(Gel Analyzer, Biorad) taken before transfer to the mem-
brane. Signal intensities were calculated using ImageJ [24]
and plotted using Excel.
Microarray hybridization and data analysis
Total RNA (2 μg) was labeled and hybridized to miCHIP
as previously described [20,21]. miCHIP is based on Tm-
normalized capture probes (miRCURY; Exiqon, Den-
mark). miRCURY probes spotted on these arrays were
designed to target 500 (miRBase v9.2 [25]) unique mouse
miRNAs. Array images were generated by using the Gene-
pix 4200AL laser scanner (Molecular Devices), miCHIP
arrays were scanned in batches using the Genepix auto
Photo Multiplayer (PMT) algorithm, with pixel saturation
tolerance set to 0.2%. Tiff images generated by the Gene-
pix 4200AL laser scanner were processed by the Genepix 6
microarray analysis software (Molecular Devices). Arti-
fact-associated spots were eliminated both by software-
and visual-guided flags. Signal intensities were measured
according to the local background subtraction method as
a function of the median of foreground pixels minus
median of background pixels. Genepix outputs files are
imported directly in Genespring and data are normalized
to the 50th percentile. Genespring build-in tools were used
to visualize box plots, scatter plots and hierarchical clus-
tering. Any additional analysis of the data is done by using
Scatter plot matrices, freshly harvested tissues Figure 5
Scatter plot matrices, freshly harvested tissues. Matrix plots indicating miRNA expression in freshly prepared tissues. 
MiRNA expression in freshly prepared liver tissue (A) only show few capture probes that indicate regulation. By contrast, 
miRNA expression in freshly prepared duodenal tissue (B) is prone to major degradation, therefore, a large number of capture 
probes indicate significant regulation.BMC Biotechnology 2009, 9:102 http://www.biomedcentral.com/1472-6750/9/102
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Excel and TIGR MeV (MultiExperiment Viewer, http://
www.tm4.org[26]). To investigate the relationship
between the affected capture probes we have used Venn
diagrams. Venn diagrams were plotted by using an online
freely available tool named Venny http://bioin-
fogp.cnb.csic.es/tools/venny/index.html.
miQPCR
For miQPCR 500 ng of total RNA were reverse transcribed
as described (miQPCR is covered by patent number EP 09
002 587.5) and 5 ng of cDNA were used for individual
assays. cDNAs were amplified by using gene specific prim-
ers and SYBR Green [Applied Biosystems (ABI), P/N
4309155] and run on a ABI 7500 instrument following
standard 7500 mode (96-well plate at 50°C for 2 min,
95°C for 10 min, followed by 40 cycles of 95°C for 15 sec,
60°C for 1 min; all reactions were run in duplicates) with
dissociation step (ramping from 60°C to 95°C) for mon-
itoring melting curve of the PCR products. After the run
threshold cycles (Ct) were defined as the fractional cycle
number at which the fluorescence passed the fixed thresh-
old[22]. Ct values were extracted by using the Prism7000
software (ABI) and plotted using Excel.
Microarray repository
Arrays results generated in this study have been deposited
in the Gene Expression Omnibus (GEO) repository and
are accessible under accession number GSE18788 and
GSE19104.
Competing interests
DI, VB, MUM and MC declare no competing financial
interests.
Venn diagrams Figure 6
Venn diagram. Venn diagrams were used to identify capture probes systematically regulated by total RNA degradation. Lists 
of significantly regulated capture probes for the defrosted liver (A) and the duodenum (B) were created and the intersection 
between the lists was assessed by using the Venn diagram. For complete probe list see Additional file 1 - Table S1.BMC Biotechnology 2009, 9:102 http://www.biomedcentral.com/1472-6750/9/102
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Effect of total RNA degradation on miQPCR data Figure 7
Effect of total RNA degradation on miQPCR data. Comparison of changes in relative expression for 7 selected miRNAs 
(Let-7b, Let-7c, Let-7d, miR-122, miR-16, miR-192 and miR-194) and RNU6 in total RNA extracted from frozen liver. For indi-
vidual miRNAs the crossing threshold (Ct) value across the seven different miRNAs is shown. Data are shown as average of 
three independent miQPCR runs ± standard deviation.BMC Biotechnology 2009, 9:102 http://www.biomedcentral.com/1472-6750/9/102
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